ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

Epstein Alleges Conflict Of Interest Of Former Chairman And Sloan-Kettering Directors

May 15, 1992

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

NCAB Approves OIA Awards For At Least 21 Scientist, More If Payline Lifted

May 24, 1985

In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs

April 24, 1981

NIH Strategic Plan To be Unveiled In San Antonio

January 31, 1992